#worldcancerday (Feb 4th) raises awareness of cancer, including research, detection, prevention, and treatment.
Porsolt is proud to announce a collaboration with the TSC Alliance and the The LAM Foundation to develop a preclinical model of lymphangioleiomyomatosis (LAM), a rare cystic-lung disease caused by genetic mutations in TSC1 or TSC2 genes. TSC and LAM share disease mechanisms with cancer and this model will provide a unique opportunity to screen candidate cancer therapeutics for this rare disease.
Please contact us to discuss your specific needs!
contact@porsolt.com
www.porsolt.com